Atlas Trials

A Study to Examine the Safety and Tolerability of MK0517 for the Prevention of Post-Operative Nausea and Vomiting (0517-015)

Clinical trial NCT00231777 · COMPLETED

Trial details

NCT number
NCT00231777
Sponsor
Merck Sharp & Dohme LLC
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Post-Operative Nausea and Vomiting
Start date
2005-07-01
Primary completion
2005-11-01
Enrollment
216

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.